141 related articles for article (PubMed ID: 20372826)
1. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.
Yang L; Luo Y; Wei J; He S
Int J Mol Med; 2010 May; 25(5):807-12. PubMed ID: 20372826
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract][Full Text] [Related]
3. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
Kotenko SV; Gallagher G; Baurin VV; Lewis-Antes A; Shen M; Shah NK; Langer JA; Sheikh F; Dickensheets H; Donnelly RP
Nat Immunol; 2003 Jan; 4(1):69-77. PubMed ID: 12483210
[TBL] [Abstract][Full Text] [Related]
4. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.
Li M; Liu X; Zhou Y; Su SB
J Leukoc Biol; 2009 Jul; 86(1):23-32. PubMed ID: 19304895
[TBL] [Abstract][Full Text] [Related]
5. IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.
Cao Y; Zhang R; Zhang W; Zhu C; Yu Y; Song Y; Wang Q; Bai L; Liu Y; Wu K; Wu J
J Immunol; 2014 Jan; 192(2):691-703. PubMed ID: 24337382
[TBL] [Abstract][Full Text] [Related]
6. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
[TBL] [Abstract][Full Text] [Related]
7. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.
Osterlund PI; Pietilä TE; Veckman V; Kotenko SV; Julkunen I
J Immunol; 2007 Sep; 179(6):3434-42. PubMed ID: 17785777
[TBL] [Abstract][Full Text] [Related]
8. The role of transposable elements in the regulation of IFN-lambda1 gene expression.
Thomson SJ; Goh FG; Banks H; Krausgruber T; Kotenko SV; Foxwell BM; Udalova IA
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11564-9. PubMed ID: 19570999
[TBL] [Abstract][Full Text] [Related]
9. Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells.
Tezuka Y; Endo S; Matsui A; Sato A; Saito K; Semba K; Takahashi M; Murakami T
Lung Cancer; 2012 Dec; 78(3):185-92. PubMed ID: 23021208
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of interleukins-28 and -29: comparison with type I interferons.
Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
[TBL] [Abstract][Full Text] [Related]
11. Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.
Bolen CR; Ding S; Robek MD; Kleinstein SH
Hepatology; 2014 Apr; 59(4):1262-72. PubMed ID: 23929627
[TBL] [Abstract][Full Text] [Related]
12. Viral infections activate types I and III interferon genes through a common mechanism.
Onoguchi K; Yoneyama M; Takemura A; Akira S; Taniguchi T; Namiki H; Fujita T
J Biol Chem; 2007 Mar; 282(10):7576-81. PubMed ID: 17204473
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
Lasfar A; Lewis-Antes A; Smirnov SV; Anantha S; Abushahba W; Tian B; Reuhl K; Dickensheets H; Sheikh F; Donnelly RP; Raveche E; Kotenko SV
Cancer Res; 2006 Apr; 66(8):4468-77. PubMed ID: 16618774
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
[TBL] [Abstract][Full Text] [Related]
15. IL28RA inhibits human epidermal keratinocyte proliferation by inhibiting cell cycle progression.
Yin X; Zhang S; Li B; Zhang Y; Zhang X
Mol Biol Rep; 2019 Feb; 46(1):1189-1197. PubMed ID: 30632069
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.
Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605
[TBL] [Abstract][Full Text] [Related]
17. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
18. IL-28, IL-29 and their class II cytokine receptor IL-28R.
Sheppard P; Kindsvogel W; Xu W; Henderson K; Schlutsmeyer S; Whitmore TE; Kuestner R; Garrigues U; Birks C; Roraback J; Ostrander C; Dong D; Shin J; Presnell S; Fox B; Haldeman B; Cooper E; Taft D; Gilbert T; Grant FJ; Tackett M; Krivan W; McKnight G; Clegg C; Foster D; Klucher KM
Nat Immunol; 2003 Jan; 4(1):63-8. PubMed ID: 12469119
[TBL] [Abstract][Full Text] [Related]
19. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
[TBL] [Abstract][Full Text] [Related]
20. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
